The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: Regulatory vs. lytic

Journal of Neuroimmunology

Volumn 98, Issue 2, 1999, Pages 136-146

  Nicholson, Simone M ^a   Haynes, Lia M ^a   Vanderlugt, Carol L ^a   Miller, Stephen D ^a   Melvold, Roger W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

EAE MS; Mouse; Neuroimmunology; T lymphocytes; TMEV

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; INFECTION RESISTANCE; IRRADIATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; DEMYELINATING DISEASES; DISEASE SUSCEPTIBILITY; FIBROSARCOMA; GAMMA RAYS; KINETICS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUROIMMUNOMODULATION; SPLEEN; THEILOVIRUS; THYMECTOMY; TUMOR CELLS, CULTURED;

EID: 0032981340     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00090-9     Document Type: Article

References (54)

1. Beall S.S., Concannon P., Charmley P., McFarland H.F., Gatti R.A., Hood L.E., McFarlin D.E., Biddison W.E. The germline repertoire of T cell receptor β-chain genes in patients with chronic progressive multiple sclerosis. J. Neuroimmunol. 21:1989;59-66.
2. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73:1992;1861-1865.
3. Bureau J.F., Montagutelli X., Lefebre S., Guenet J.-L., Pla M., Brahic M. The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J. Virol. 66:1992;4698-4704.
4. Bureau J.F., Montagutelli X., Bihl F., Lefebre S., Guenet J.-L., Brahic M. Genetic analysis of the persistence of Theiler's virus in the central nervous system of the mouse. Nature Genetics. 5:1993;87-91.
5. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed type hypersensitivity. J. Immunol. 135:1985;1408-1414.
6. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136:1986;920-927.
7. Clatch R.J., Lipton H.L., Miller S.D. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb. Pathog. 3:1987;327-337.
8. Clatch R.J., Melvold R.W., Dal Canto M.C., Miller S.D., Lipton H.L. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B and C. J. Neuroimmunol. 15:1987;121-135.
9. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection. Lab. Invest. 33:1976;626-637.
10. Fiette L., Aubert C., Brahic M., Pena Rossi C. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:1993;589-592.
11. Fitch F.W., Stack R., Fields P., Lancki D.W., Cronin D.C. Regulation of T lymphocyte subsets. Ciba Found. Symp. 195:1995;68-80.
12. Fong T.A., Mosmann T.R. Alloreactive murine CD8+T cell clones secrete the Th1 pattern of cytokines. J. Immunol. 144:1990;1744-1752.
13. Gerety S.J., Rundell M.K., Dal Canto M.C., Miller S.D. Class II-restricted T cell responses in Theiler's murine encephalomyelitis (TMEV)-induced demyelinating disease: VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:1994;919-929.
14. Haines J.L., Ter-Minassian M., Bazyk A.et al. A complete genomic screening for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genetics. 13:1996;469-471. 26 additional authors.
15. Hashimoto L.L., Mak T.W., Ebers G.C. T-cell alpha chain polymorphisms in multiple sclerosis. J. Neuroimmunol. 40:1992;41-48.
16. Inoue T., Asano Y., Matsuoka S., Furutani-Seiki M., Aizawa S., Nishimura H., Shirai T., Tada T. Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J. Immunol. 150:1993;2121-2128.
17. Jelachich M.L., Bandyopadhyay P., Blum K., Lipton H.L. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology. 209:1995;437-444.
18. Kappel C.A., Dal Canto M.C., Melvold R.W., Kim B.S. Hierarchy of effects of the major histocompatibility complex and T cell receptor β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147:1991;4322-4326.
19. Kuokkanen S., Sundvall M., Terwilliger J.D., Tienari P.J., Wikstrom J., Holmdahl R., Petterson U., Pelronen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nature Genetics. 13:1996;477-480.
20. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:1993;382-427.
21. Lin X., Thiemann N.R., Pease L.R., Rodriguez M. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology. 214:1995;91-99.
22. Lindsley M.D., Thiemann R., Rodriguez M. Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 65:1991;6612-6620.
23. Lipton H.L., Dal Canto M.C. Susceptibility of inbred mice to encephalomyelitis virus. Infect. Immun. 26:1979;369-374.
24. Lipton H.L., Melvold R.W. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1984;1821-1825.
25. Lipton, H.L., Miller, S.D., Melvold, R.W., Fujimani, R.S., 1986. Theiler's murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis. In: Notkins, A.L., Oldstone, M.B.A. (Eds.), Concepts in Viral Pathogenesis II. Springer-Verlag, New York, pp. 248-254.
26. Lipton H.L., Melvold R.W., Miller S.D., Dal Canto M.C. Mutation of a major histocompatibility class I locus, H-2D leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J. Neurovirol. 1:1995;138-144.
27. Melvold, R.W., Jokinen, D.M., Miller, S.D., Dal Canto, M.C., Lipton, H.L., 1987a. H-2 genes in TMEV-induced demyelination, a model for multiple sclerosis. In: David, C. (Ed.), Major Histocompatibility Genes and Their Role in Immune Function. Plenum, New York, pp. 735-745.
28. Melvold R.W., Jokinen D.M., Knobler R.L., Lipton H.L. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta chain constant gene on chromosome 6. J. Immunol. 138:1987;1429-1433.
29. Melvold R.W., Jokinen D.M., Miller S.D., Dal Canto M.C., Lipton H.L. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. Virol. 64:1990;686-690.
30. Miller S.D., Gerety S.J. Immunologic aspects of Theiler's murine encephalo-myelitis virus (TMEV)-induced demyelinating disease. Sem. Virol. 1:1990;263-272.
31. Miller, S.D., Karpus, W.J., Pope, J.G., Dal Canto, M.C., Melvold, R.W., 1994. Theiler's murine encephalomyelitis virus-induced demyelinating disease. In: Cohen, I.R. (Ed.), Animal Models for Autoimmune Diseases. Academic Press, pp. 23-38.
32. Nicholson S., Peterson J.D., Miller S.D., Dal Canto M.C., Melvold R.W. BALB/c substrain variation in susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. Neuroimmunol. 52:1994;19-24.
33. Nicholson S.M., Jokinen D.M., Dal Canto M.C., Kim B.S., Melvold R.W. Genetic analysis of susceptibility of the SWR strain to TMEV-induced demyelinating disease. J. Neuroimmunol. 59:1995;19-28.
34. + T lymphocytes provide protection against TMEV-induced demyelinating disease. J. Immunol. 156:1996;1276-1283.
35. Oksenberg J.R., Sherritt M., Begovich A.B., Erlich H.A., Bernard C.C., Cavalli-Sforza L.L., Steinman L. T-cell receptor Vα and Cα alleles associated with multiple sclerosis and myasthenia gravis. Proc. Natl. Acad. Sci. USA. 86:1989;988-992.
36. Olsberg C.A., Pelka A., Creighton T.M., Miller S.D., Waltenbaugh C.R., Dal Canto M.C., Lipton H.L., Melvold R.W. Induction of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Reg. Immunol. 5:1993;1-10.
37. Patick A.K., Pease L.R., David C.S., Rodriguez M. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64:1990;5570-5576.
38. Pelka A.E., Olsberg C.A., Miller S.D., Waltenbaugh C.R., Dal Canto M.C., Melvold R.W. Effects of irradiation on resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Cell. Immunol. 152:1993;440-455.
39. Pena Rossi C., McAllister A., Fiette L., Brahic M. Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell. Immunol. 138:1991;341-348.
40. Peterson J.D., Waltenbaugh C., Miller S.D. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology. 75:1992;652-658.
41. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class-I deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:1993;2287-2293.
42. Pullen L.C., Park D.H., Miller S.D., Dal Canto M.C., Kim B.S. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:1995;4497-4503.
43. Rodriguez M., David C.S. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:1985;2145-2148.
44. d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:1995;111-117.
45. Rodriguez M., Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt2-antibody. J. Immunol. 140:1988;2950-2955.
46. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:1986;620-631.
47. Rodriguez M., Pease L.R., David C.S. Immune-mediated injury of virus-infected oligodendrocytes. A model of multiple sclerosis. Immunol. Today. 7:1986;359-363.
48. Rodriguez M., Patick A.K., Pease L.R. Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J. Neuroimmunol. 26:1990;189-199.
49. Rodriguez M., Patick A.K., Pease L.R., David C.S. Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice. J. Immunol. 148:1992;921-927.
50. b mice deficient in beta 2-microglobulin. J. Immunol. 151:1993;266-276.
51. Sawyer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genetics. 13:1996;464-468.
52. Simas J.P., Fazakerley J.K. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis. J. Gen. Virol. 77:1996;2701-2711.
53. Spielman R.S., Nathanson N. The genetics of susceptibility to multiple sclerosis. Epidemiol. Rev. 4:1982;45-65.
54. Teuscher C., Rhein D.M., Livingstone K.D., Paynter R.A., Nicholson S.M., Melvold R.W. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice. J. Immunol. 159:1997;4930-4934.